CTX310
Live / Registered — Registered (as of 28 Oct 2025)
What this means for you
Registered since 28 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97461217
- Registration number
- 8005333
- Mark type
- Stylized text
- Filed
- 16 Jun 2022
- Published for opposition
- 23 Apr 2024
- Registered
- 28 Oct 2025
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy
- Class 042 — Scientific and technological services: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy
Owner
- CRISPR Therapeutics AG, ZUG V8 SWITZERLAND, CH
- CRISPR Therapeutics AG, ZUG V8 SWITZERLAND, CH
- CRISPR Therapeutics AG, ZUG V8 SWITZERLAND, CH
Prosecution history
- 28 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 09 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Jun 2025 — NON-FINAL ACTION E-MAILED
- 12 Jun 2025 — SU - NON-FINAL ACTION - WRITTEN
- 15 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 May 2025 — ASSIGNED TO LIE
- 30 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED